Maridea Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,450
Closed -$210K 493
2025
Q4
$210K Sell
8,450
-1,364
-14% -$34.4K 0.03% 383
2025
Q3
$242K Buy
9,814
+208
+2% +$5.13K 0.04% 364
2025
Q2
$233K Sell
9,606
-12,879
-57% -$300K 0.06% 240
2025
Q1
$570K Sell
22,485
-4,796
-18% -$125K 0.19% 105
2024
Q4
$724K Buy
+27,281
New +$740K 0.23% 72

Other funds holding PFE

Maridea Wealth Management's PFE Position: Q1 2026 in Review

Maridea Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 8,450 shares — an estimated $210K sold.

Maridea Wealth Management first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $724K in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Maridea Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Maridea Wealth Management sold 8,450 Pfizer shares in Q1 2026, an estimated $210K.
  • Maridea Wealth Management first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
  • Maridea Wealth Management's Pfizer position peaked at $724K in Q4 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Maridea Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.